Spyre Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYRE and other ETFs, options, and stocks.

About SYRE

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.

CEO

Cameron Turtle

CEOCameron Turtle

Employees

Employees30

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2013

Founded2013

Employees

Employees30

SYRE Key Statistics

Market cap

1.31B

Market cap1.31B

Price-Earnings ratio

-0.48

Price-Earnings ratio-0.48

Dividend yield

—

Dividend yield—

Average volume

343.32K

Average volume343.32K

High today

$39.04

High today$39.04

Low today

$35.18

Low today$35.18

Open price

$37.00

Open price$37.00

Volume

110.32K

Volume110.32K

52 Week high

$47.97

52 Week high$47.97

52 Week low

$2.66

52 Week low$2.66

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell